DSE : BEACONPHAR

Beacon Pharmaceuticals PLC — Key statistics

Pharmaceutical Preparations · Bangladesh

Last price 92.7 BDT (At close: Oct 29, 2026) · Market cap 21.41B

Latest research: Beacon Pharmaceuticals valuation report: fair value BDT 22–88.1 (Oct 2026) · Beacon's profit doubled in FY2026, but 16% long-run returns support a fair value range of BDT 22–88 (base 52)

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Key statistics

Valuation

MeasureValue
Market Cap21.41B
Enterprise Value30.45B

Dates

MeasureValue
Earnings DateOct 19, 2026
Ex-Dividend DateNov 11, 2026

Shares

MeasureValue
Current Share Class231.00M
Shares Outstanding231.00M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Ratios

MeasureValue
PE Ratio14.70
Forward PEn/a
PS Ratio1.38
PB Ratio2.76
P/TBV Ratio2.77
P/FCF Ratio14.32
P/OCF Ratio8.48
PEG Ration/a

Evratios

MeasureValue
EV / Earnings20.90
EV / Sales1.96
EV / EBITDA8.29
EV / EBIT9.88
EV / FCF20.36

Financialposition

MeasureValue
Current Ratio1.61
Quick Ratio0.46
Debt / Equity1.22
Debt / EBITDA2.57
Debt / FCF6.32
Interest Coverage2.36

Financialefficiency

MeasureValue
Return on Equity (ROE)n/a
Return on Assets (ROA)n/a
Return on Invested Capital (ROIC)14.39%
Return on Capital Employed (ROCE)25.66%
Weighted Average Cost of Capital (WACC)5.92%
Revenue Per Employee3.26M
Profits Per Employee305,379
Employee Count4,771
Asset Turnovern/a
Inventory Turnovern/a

Taxes

MeasureValue
Income Tax561.64M
Effective Tax Rate27.82%

Stockprice

MeasureValue
Beta (5Y)-0.02
52-Week Price Change-18.11%
50-Day Moving Average101.49
200-Day Moving Average104.42
Relative Strength Index (RSI)32.39
Average Volume (20 Days)87,507

Shortselling

MeasureValue
Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Incomestatement

MeasureValue
Revenue15.57B
Gross Profit8.09B
Operating Income3.08B
Pretax Income2.02B
Net Income1.46B
EBITDA3.64B
EBIT3.08B
Earnings Per Share (EPS)6.31

Balancesheet

MeasureValue
Cash & Cash Equivalents412.27M
Total Debt9.45B
Net Cash-9.04B
Net Cash Per Share-39.13
Equity (Book Value)7.75B
Book Value Per Share33.55
Working Capital5.44B

Cashflow

MeasureValue
Operating Cash Flow2.52B
Capital Expenditures-1.03B
Depreciation & Amortization560.52M
Net Borrowing-948.32M
Free Cash Flow1.50B
FCF Per Share6.47

Margins

MeasureValue
Gross Margin51.95%
Operating Margin19.80%
Pretax Margin12.97%
Profit Margin9.36%
EBITDA Margin23.40%
EBIT Margin19.80%
FCF Margin9.61%

Dividends

MeasureValue
Dividend Per Share2.10
Dividend Yield2.27%
Dividend Growth (YoY)-47.62%
Years of Dividend Growth2
Payout Ratio18.46%
FCF Payout Ratio16.99%
Buyback Yieldn/a
Shareholder Yield2.27%
Earnings Yield6.80%
FCF Yield6.98%

Analystforecasts

MeasureValue
Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Stocksplits

MeasureValue
Last Split DateNov 27, 2011
Split TypeForward
Split Ratio1.05

Scores

MeasureValue
Altman Z-Score3.04
Piotroski F-Score4

Fairvalue

MeasureValue
Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside